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ARDS and ALI
In an observational, 4-month study performed in a refer-
ence centre in France, Roch et al. [1] compared
characteristics, clinical evolution and outcome of adult
patients with acute respiratory distress syndrome (ARDS)
associated with influenza A (H1N1), treated with (nine
patients) or without (nine patients) extracorporeal
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membrane oxygenation (ECMO). Before ECMO, patients
had refractory respiratory failure (PaO2/FiO2 52 mmHg,
PaCO2 85 mmHg). Six ECMO treatments were initiated
in the referral hospital by a mobile team. Patients treated
with or without ECMO had the same hospital mortality
rate (56%). Duration of ECMO therapy was longer in
survivors than in non-survivors (9 vs. 5 days). After
ECMO initiation, early improvement of PaO2/FiO2 was
greater in survivors than in non-survivors. Haemorrhagic
complications occurred in 44% of ECMO patients, but
none required surgical treatment. The conclusion was that
ECMO may be an effective salvage treatment for patients
with influenza A (H1N1)-related ARDS presenting rapid
refractory respiratory failure, particularly when provided
early in a specialized reference centre.
In an accurate meta-analysis Sud et al. [2] analysed the
effects of prone versus supine ventilation in acute hyp-
oxaemic respiratory failure (AHRF) and severe
hypoxaemia (PaO2/FiO2 \ 100 mmHg) compared with
moderate hypoxemia (PaO2/FiO2 between 100 and
300 mmHg). Ten trials (N = 1,867 patients) met inclu-
sion criteria; most patients had acute lung injury.
Methodological quality was relatively high. Prone venti-
lation reduced mortality in patients with PaO2/FiO2 below
100 mmHg [risk ratio (RR) 0.84, 95% confidence interval
(CI) 0.74–0.96; p = 0.01; seven trials, N = 555] but not
in patients with PaO2/FiO2 equal to or higher than
100 mmHg (RR 1.07, 95% CI 0.93–1.22; p = 0.36; seven
trials, N = 1,169). Post hoc analysis demonstrated sta-
tistically significant improved mortality in the more
hypoxaemic subgroup and significant differences between
subgroups using a range of PaO2/FiO2 thresholds up to
approximately 140 mmHg. Prone ventilation improved
oxygenation by 27–39% over the first 3 days of therapy
but increased the risks of pressure ulcers (RR 1.29, 95%
CI 1.16–1.44), endotracheal tube obstruction (RR 1.58,
95% CI 1.24–2.01) and chest tube dislodgement (RR
3.14, 95% CI 1.02–9.69). The authors concluded that
prone ventilation reduces mortality in patients with severe
hypoxaemia, but given the associated risks, the prone
position should not be routine in all patients with AHRF,
but may be considered for severely hypoxaemic patients.
Laminin-5, a cell adhesive molecule expressed solely
by the epithelium, is known to enhance epithelial cell
migration and repair of the injured epithelium. Its physi-
ological role in alveolar epithelial injury remains
unknown. The terminal gamma 2 fragment (G2F) of
laminin-5 can be detected in the peripheral blood. Ka-
tayama et al. [3] examined the relationship between
disease status and alveolar laminin-5 accumulation during
the exudative phase in patients with acute lung injury
(ALI), as reflected by circulating G2F levels. Sampling of
epithelial lining fluids or pulmonary edema fluids from
patients with acute lung injury ALI or related diseases
was performed. Plasma samples were obtained from them
at the time of disease onset or later. The authors found a
significantly higher amount of G2F in pulmonary edema
and epithelial lining fluids of patients with ALI, as com-
pared with those with the other respiratory diseases. The
plasma levels were also elevated significantly early at the
onset of ALI (mean ± SD, 147 ± 82 ng/ml in non-sur-
viving and 90 ± 56 in surviving patients) as compared
with those in the patients with cardiogenic pulmonary
edema (59 ± 36) or idiopathic pulmonary fibrosis
(37 ± 17). At 5 days after onset, non-surviving patients
maintained higher plasma concentrations (152 ± 84), but
in contrast, the levels in surviving patients declined
(71 ± 35), suggesting secretion of laminin-5 was sup-
pressed, associated with recovery from ALI. It was
concluded that circulating G2F may be a useful biomarker
to monitor the pneumocyte re-epithelialization process
during alveolar repair in ALI patients.
Pulmonary hypertension is a characteristic feature of
ARDS and contributes to mortality. Phosphodiesterases
(PDE) inactivate cyclic GMP and thus relaxation of
smooth muscle cell is inhibited. Cornet et al. [4] con-
ducted a study to investigate whether sildenafil, which
selectively inhibits the isoenzyme PDE5, is beneficial for
patients with ARDS. Ten consecutive ARDS patients
received a single dose of 50 mg sildenafil via a naso-
gastric tube. Sildenafil decreased mean pulmonary arterial
pressure from 25 to 22 mmHg (p = 0.022) and pulmon-
ary artery occlusion pressure from 16 to 13 mmHg
(p = 0.049). Systemic mean arterial pressures were
markedly decreased from 81 to 75 mmHg (p = 0.005).
Sildenafil did not improve pulmonary arterial oxygen
tension, but resulted in a further increase in the shunt
fraction. It was concluded that the results did not justify a
routine place for sildenafil in the treatment of ARDS
patients. This article was accompanied by an editorial [5].
Transfusion of blood components is common in
patients admitted to the intensive care unit (ICU) for
gastrointestinal (GI) bleeding. However, the incidence
and risk factors for development of transfusion-related
acute lung injury (TRALI) in these patients are unknown.
Data on 255 patients admitted to a medical ICU for GI
bleeding and with specific risk factors for development of
TRALI were analysed in a paper published in the October
issue [6]. In transfused patients (n = 150), the incidence
of TRALI was 15% and accounted for 76% (22/29) of all
ALI cases. Transfused patients with end-stage liver dis-
ease (ESLD; n = 72) developed TRALI more frequently
than those without ESLD (29 vs. 1%, p \ 0.01). Fresh
frozen plasma (FFP) was temporally associated with
TRALI in 86% of cases. Transfusion-specific risk factors
for development of TRALI included number of transfused
units of FFP and non-leukoreduced red blood cells.
Patient-specific risk factors included model for ESLD
score, admission serum albumin level, and presence of
ALI risk factors. It was concluded that TRALI is common
in critically ill ESLD patients with GI bleeding. Non-
leukoreduced red blood cells and FFP are significant
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transfusion-specific risk factors and their use should be re-
evaluated in these patients.
Acute respiratory failure might be a cause of ICU
admission of pregnant and postpartum women. A sys-
tematic review of studies reporting the incidence and
characteristics of these patients was published in the
September issue [7]. A total of 40 eligible studies
reporting outcomes for 7,887 women were analysed. All
studies were retrospective with the majority reporting data
from a single centre. The incidence of ICU admission
ranged from 0.7 to 13.5 per 1,000 deliveries. Pregnant or
postpartum women accounted for 0.4–16.0% of ICU
admissions. Hypertensive disorders with acute respiratory
failure were the most prevalent indication for ICU
admission [median 0.9 cases per 1,000 deliveries (range
0.2–6.7)]. There was no difference in the profile of ICU
admission in developing compared to developed coun-
tries, except for the significantly higher maternal
mortality rate in developing countries (median 3.3 vs.
14.0%, p = 0.002). Studies reporting patient outcomes
subsequent to ICU admission are lacking. Pollock et al.
[7] concluded that ICU admission of pregnant and post-
partum women occurs infrequently. The ICU admission
profile of women was similar in developed and develop-
ing countries; however, the maternal mortality rate
remains higher for ICUs in developing countries. The ICU
admission is potentially a useful indicator of severe
maternal morbidity that captures data on women with the
most severe disease.
Clinical applications of quantitative computed
tomography (qCT) in patients with pulmonary opacities
and ARDS are important, but are hindered by the radia-
tion exposure and by the arduous manual image
processing. Reske et al. [8] hypothesized that extrapola-
tion from only ten thoracic CT sections will provide
reliable information about the aeration of the entire lung.
A retrospective analysis of CTs of 72 patients with normal
and 85 patients with opacified lungs was done. Volumes
and masses of the lung and its differently aerated com-
partments were obtained from all CT sections. Then only
the most cranial and caudal sections and a further eight
evenly spaced sections between them were selected. The
results from these ten sections were extrapolated to the
entire lung. The median (range) total lung volume was
3,738 (1,311–6,768) ml, and the 95% limits of agreement
were 26 (-42 to 95) ml. The median volumes (range) of
differently aerated compartments (percentage of total lung
volume) were 1 (0–54)% for the non-aerated, 5 (1–44)%
for the poorly aerated, 85 (28–98)% for the normally
aerated and 4 (0–48)% for the hyperaerated compartment.
The agreement between the extrapolated results and those
from all CT sections was excellent: the limits of agree-
ment never exceeded ±2%. It was concluded that the
extrapolation method can reduce radiation exposure and
shorten the time required for qCT analysis of lung aera-
tion and thus foster the application of the technique into
research and clinical practice. This article has an editorial
comment [9].
Giraud and co-workers [10] tested whether the moni-
toring of transpulmonary thermodilution curves can be
used for detecting shunt. It is an interesting approach in
which the authors tried to detect a vascular shunt between
the arterial and venous side in the systemic circulation.
Such shunt causes an early recirculation of the indicator.
As a result of the low signal to noise ratio it can be
difficult to detect early recirculation of the thermal indi-
cator but it will also have an effect on the calculation of
extravascular lung water (reflecting lung edema). By
measuring obviously overestimated lung water, attention
should be paid to the possible presence of a circulatory
shunt (arteriovenous fistula?).
Mechanical ventilation
Ventilator performances and patient–ventilator
interaction
Two studies evaluated performances of modern mechan-
ical ventilators in specific conditions. In a bench study,
Lyazidi et al. [11] assessed the performance of algorithms
used by nine ICU ventilators to compensate for the vol-
ume compressed into the circuit and evaluated the
accuracy of tidal volume delivered during volume-con-
trolled ventilation. Measurements were performed under
different conditions of respiratory mechanics, taking also
into account humidity and temperature of the delivered
gas. Delivered volume differed significantly across ven-
tilators with an error range of -15 to 32% for set tidal
volume, which represents 1–2 ml/kg for a preset tidal
volume of 6 ml/kg predicted body weight. Respiratory
system mechanics and application of an inspiratory pause
significantly affected tidal volume actually delivered.
Lyazidi et al. concluded that the difference between preset
tidal volume and volume actually delivered is clinically
meaningful and differs across modern ICU ventilators. In
a multicentre randomized cross-over study, Vignaux et al.
[12] evaluated the impact of noninvasive ventilation
(NIV) algorithms available on modern ICU ventilators on
the incidence of patient–ventilator asynchrony in 65
patients with acute respiratory failure. Although overall
asynchrony was unchanged, the mean number of asyn-
chronies influenced by leaks was significantly reduced by
activating the NIV mode (from 28 to 12% without and
with the NIV algorithm, respectively). In particular,
ineffective efforts and late cycling significantly
decreased, but some NIV algorithms tended to promote
premature cycling. In conclusion, NIV algorithms pro-
vided by ICU ventilators can reduce the incidence of leak-
associated asynchronies, while not necessarily changing
the overall asynchrony.
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A new device, the PVI monitor, has been proposed to
monitor and improve patient–ventilator interaction [13].
This device can calculate the patient’s total inspiratory
muscle pressure using estimated values of resistance and
elastance of the respiratory system. Kondili et al. [14]
evaluated the accuracy of the new device to quantify
inspiratory muscle pressure by comparing values of total
inspiratory muscle pressure measured using the trans-
diaphragmatic/esophageal pressure to those calculated by
the PVI monitor in 11 patients ventilated with propor-
tional assist ventilation plus. Values of inspiratory muscle
pressure and inspiratory and expiratory time did not differ
among the various methods of calculation. Inspiratory
muscle pressure decreased with increasing the level of
ventilator assistance, and the magnitude of this decrease
did not differ among the various methods. Kondili et al.
concluded that the PVI monitor may be used to provide
breath-by-breath quantitative information about inspira-
tory muscle pressure in mechanically ventilated patients.
Synchrony between patient and ventilator strongly
depends on settings and interfaces. Costa et al. [15]
evaluated patient–ventilator interaction during pressure
support ventilation (PSV) delivered with three interfaces:
endotracheal tube (ET), face mask (FM) and helmet (H).
The study was performed at different pressurization times
(Time (press)), cycling-off flow thresholds (Tr (exp)) and
respiratory rates in a bench study, and with FM and H in a
healthy volunteers study. PSV was delivered through the
three interfaces with three different respiratory rates in the
bench study, and through FM and H at two different
respiratory rates in the human study. The tested ventilator
settings expressed as Time (press)/Tr (exp) were 50%/
25% (default setting), 20%/5% (slow setting) and 80%/
60% (fast setting). The patient–ventilator synchrony was
significantly better with ET, with significantly lower
inspiratory trigger delay and significantly higher time of
assistance. The slow setting at respiratory rates of 30
breaths per minute produced the worst interaction, with
higher rates of wasted efforts compared with the fast
setting (20, 40 and 50% of wasted efforts versus 0, 16 and
26% of all spontaneous breaths, with ET, FM and H,
respectively; p \ 0.01). In both studies the FM resulted in
better synchrony as compared with the H. It was con-
cluded that patient–ventilator synchrony was significantly
better with the ET than with the FM or H in the bench
study. In vivo, the FM outperformed the H and fast set-
tings can correct some of the limitations in terms of
synchrony.
Modes of ventilation
Bilevel positive airway pressure ventilators, commonly
employed to deliver NIV, use single-limb tubing which
can increase the amount of CO2 rebreathing. Szkulmow-
ski et al. [16] measured the amount of rebreathing with
such ventilator circuits and assessed predictive factors for
CO2 re-inhalation in patients receiving PSV, either
through an endotracheal tube or with a NIV mask. Only
19% of the measured cycles had an inspired fraction of
CO2 greater than 0.1%. Four parameters were able to
predict CO2 rebreathing: high end-tidal CO2, low positive
end-expiratory pressure (PEEP), intubation and high
respiratory rate. These results suggest that the risk of
rebreathing with bilevel ventilators in the clinical setting
is modest; application of PEEP and avoidance of high
respiratory rates can further decrease this risk.
Several studies evaluated new ventilatory modes and
techniques. Isgro` et al. [17] described a new continuous
positive airway pressure (CPAP) system equipped with an
electromechanical expiratory valve designed to switch
between two PEEP levels on a time-cycled basis. By
using such a device, the authors investigated the effects
on oxygenation of applying a sigh (2 high pressure
breaths per minute) or a biphasic positive pressure ven-
tilation (10 mandatory breaths per minute) in patients
with hypoxic respiratory failure undergoing continuous
flow CPAP with a helmet. As compared with CPAP
alone, the application of periodic sighs and biphasic
positive airway pressure (BIPAP) induced a similar
improvement in oxygenation which was maintained for at
least 1 h after returning to standard CPAP. Isgro` et al.
concluded that periodic, non-synchronized higher pres-
sure breaths delivered at a rate as low as 2 breaths/min
may improve oxygenation during helmet CPAP in hyp-
oxaemic patients. Iotti et al. [18] reported the results of a
multicentre, crossover trial performed to assess the short-
term effects of adaptive support ventilation (ASV) as
compared with conventional volume or pressure-control
ventilation in 88 patients with acute respiratory failure
undergoing total ventilatory support. As compared with
conventional ventilation and at the same minute ventila-
tion, ASV resulted in a slightly lower PaCO2 without
changes in oxygenation. During ASV, respiratory rate
was slightly lower and tidal volume slightly greater than
conventional ventilatory modes, especially in patients
with obstructive disease. The ventilatory patterns selected
by ASV were similar to those chosen by the clinicians
during conventional ventilation: tidal volume was lower
in patients with restrictive disease and expiratory time
was prolonged in obstructed patients. With ASV, tidal
volume was, however, unacceptably high in 11% of
chronic obstructive pulmonary disease patients. Iotti et al.
concluded that, as compared with conventional ventila-
tion, ASV resulted in a similar ventilatory pattern and, in
35% of patients, in a more efficient CO2 elimination.
Gonza´lez et al. [19] performed a case-matched analysis
according to a propensity score to compare characteristics
and clinical outcomes of 234 patients receiving airway
pressure release ventilation (APRV) or BIPAP with those
of 1,228 patients ventilated with assist-control ventilation
(A/C) only. APRV/BIPAP was used only in selected
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geographic areas (84% patients in Germany). Patients
were less likely to be ventilated with APRV/BIPAP in the
case of coma or congestive heart failure, pH \ 7.15 prior
to mechanical ventilation, and respiratory failure devel-
oping after intubation. No differences in clinical
outcomes were observed between groups.
A novel adaptive control system for noisy pressure-
controlled ventilation was proposed in ‘‘a numerical
simulation and bench test study’’ by Gama de Abreu’s
research group [20]. They developed and evaluated a
control system based on the least-mean-squares adaptive
approach that enables an automatic and continuous
adjustment of the driving pressure during pressure-con-
trolled ventilation to achieve desired variability in the
tidal volume. Their conclusion is that the control system
works under model experimental conditions, which is
obviously a step before the clinical testing. It should be
emphasized that the same group has demonstrated a
number of advantages using noisy ventilation with
improved respiratory mechanics and gas exchange.
ECMO can support oxygenation and carbon dioxide
elimination in severe lung failure. Usually it is accom-
panied by controlled mechanical ventilation. Neurally
adjusted ventilatory assist (NAVA) may allow a close
interaction between ventilation and extracorporeal perfu-
sion. In a pilot study, Karagiannidis et al. [21] intended to
measure the physiologic ventilatory response in patients
with severe lung failure treated with ECMO and NAVA.
The authors hypothesized that the combination of both
methods could automatically provide a protective venti-
lation with optimized blood gases. A case series of six
patients treated with ECMO for severe lung failure is
described. Tidal volumes on ECMO ranged between 2
and 5 ml/kg predicted body weight and increased up to
8 ml/kg with inactivated ECMO. Ventilatory response to
decreased sweep gas flow was rapid, and patients imme-
diately regulated PaCO2 tightly towards a physiological
pH value. Increase in minute ventilation was a result of
increased breathing frequency and tidal volumes. It was
concluded that combination of NAVA and ECMO may
permit a closed-loop ventilation with automated protec-
tive ventilation.
High-frequency oscillation (HFO) and tracheal gas
insufflation (TGI) are employed in patients with ALI/
ARDS to enhance oxygenation and CO2 elimination.
Mentzelopoulos et al. [22] compared HFO with and
without TGI at the same mean tracheal pressure, to assess
whether TGI can improve gas exchange independently
from tracheal pressure. Two levels of mean tracheal
pressure were studied. HFO with TGI resulted in better
oxygenation (at both mean tracheal pressures) and lower
PaCO2 (at the higher level of tracheal pressure) than HFO
alone. The authors concluded that, at equal level of tra-
cheal pressure, combining HFO with TGI resulted in
better gas exchange than standard HFO. High-frequency
percussive ventilation (HFPV) has been suggested to be
beneficial in ARDS patients. Lucangelo et al. [23] per-
formed a bench study in a bicompartmental mechanical
lung model to assess whether and how varying the
resistive and elastic loads applied to one compartment
only would modify gas distribution between the two
pathways under HFPV and pressure-controlled ventila-
tion. With HFPV, hyperinflation was prevented and tidal
volume was reduced. Gas distribution between the two
compartments differed according to the ventilatory mode:
unlike pressure-controlled ventilation, gas distribution
with HFPV was not determined by the time constant of
each compartment. In conclusion, HFPV accommodated
volume distribution without overinflating compartments
with low time constants, thus possibly presenting a
potential protective behaviour in mechanically heteroge-
neous lungs.
Noninvasive ventilation
Several studies were dedicated to NIV. Phua et al. [24]
evaluated the role of NIV in acute respiratory failure
associated with bronchiectasis: the authors retrospectively
reviewed bronchiectatic patients placed on NIV (n = 31)
or invasive mechanical ventilation (IMV; n = 26) for
acute respiratory failure over 8 years. At baseline, the
NIV group had more patients with acute exacerbations
without identified precipitating factors (87.1 vs. 34.6%),
higher pH (mean 7.25 vs. 7.18) and PaO2/FiO2 ratio
(mean 249.4 vs. 173.2, p = 0.02), and a trend towards a
lower APACHE II score than the IMV group. There was
no difference in hospital mortality between the two
groups (25.8 vs. 26.9%, p [ 0.05). The NIV failure rate
was 32.3%. Using logistic regression, Phua et al. found
that the APACHE II score was the only predictor of
hospital mortality, and the PaO2/FiO2 ratio was the only
predictor of NIV failure.
The possible role of small dead space heat and mois-
ture exchangers (HME) during NIV was assessed in
comparison with a heated humidifier (HH) [25]. The
effects of HME and HH on respiratory rate, minute ven-
tilation, EtCO2, oxygen saturation, airway occlusion
pressure at 0.1 s, arterial blood gases (ABG), and comfort
perception were compared during two randomly deter-
mined NIV periods of 30 min. No difference was
observed between HME and HH suggesting that if one
decides to humidify patients’ airways during NIV, one
may do so with small dead space HME or HH without
altering respiratory parameters.
Fartoukh et al. [26] evaluated the use of early inter-
mittent NIV for acute chest syndrome (ACS) in adults
with sickle cell disease in a pilot study. Seventy-one
consecutive ACS episodes in 67 patients were randomly
allocated to oxygen (n = 36) or NIV (n = 35) for 3 days
in a medical step-down unit. Baseline respiratory rate and
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pain score were higher in the NIV group. NIV promptly
lowered the respiratory rate, raised PaO2, and decreased
alveolar–arterial oxygen gradient (A-a)O2, which
remained unchanged with oxygen alone. PaCO2 signifi-
cantly worsened only in the oxygen group. On day 3, the
groups did not differ regarding the proportion of episodes
with normal PaO2. In the subgroup of patients with severe
hypoxaemia, physiological variables also improved faster
with NIV.
The use of NIV for diagnostic bronchoscopy using a
new face mask was evaluated by Heunks et al. [27]. A
commercially available full-face mask was modified to
allow introduction of the bronchoscope without interfer-
ing with the ventilator circuit. Bronchoscopy with
bronchoalveolar lavage was performed in 12 hypoxaemic
non-ICU patients during NIV in the ICU. Oxygenation
improved after initiation of noninvasive positive pressure
ventilation. In all patients the procedure could be com-
pleted without subsequent complications, although in one
patient SpO2 decreased until 86% during bronchoscopy.
A microbiological diagnosis could be established in 8 of
12 patients with suspected infection.
The problem of sedation during NIV was evaluated by
Clouzeau et al. [28] studying the use of target-controlled
infusion (TCI) of propofol for sedation in patients with
noninvasive ventilation failure due to low tolerance. Ten
patients with NIV failure due to discomfort, agitation and/
or refusal to continue with this ventilatory support were
included; seven had acute respiratory failure and three
had acute hypercapnic respiratory failure. Patients were
sedated by TCI of propofol during NIV sessions. Blood
gas analysis, cardiorespiratory and ventilatory parameters,
propofol concentration (Cpt) required, comfort and
adverse events were recorded. NIV under TCI of propofol
significantly improved arterial blood gas analyses; three
patients required endotracheal intubation, two due to
evolution of underlying disease and one because of a
seizure disorder. Eight patients were discharged from the
ICU and two died, suggesting that in a selected popula-
tion, TCI of propofol can facilitate acceptance of NIV.
Mask intolerance and discomfort are factors related to
NIV failure. Analgesia-based sedation has been proposed
to manage NIV failure in patients with acute respiratory
failure. Rocco et al. [29] aimed to assess the feasibility of
remifentanil-based sedation in hypoxaemic acute respi-
ratory failure (HARF) patients refusing to continue NIV
for intolerance to two different interfaces: helmet and
total face mask. Thirty-six patients with persistent severe
HARF who complained of discomfort and asked for
interruption of NIV session were prospectively studied.
Patients started sedation with remifentanil (0.025 lg/kg/
min/kg) and the infusion rate was increased by 0.01 lg/
kg/min every minute to a maximum of 0.12 lg/kg/min to
obtain patient comfort. Twenty-two out of 36 patients
(61%) continued the NIV treatment after the introduction
of remifentanil infusion. In this success group, median
(interquartile range, IQR) respiratory rate decreased from
34 (31, 37) to 24 (20, 26) per min (p \ 0.0001) and PaO2/
FiO2 ratio increased from 156 (144, 176) to 270 (210,
300) mmHg (p \ 0.0001) after 1 h of NIV with remif-
entanil, either with a helmet or total face mask. Fourteen
patients failed to continue NIV and were intubated after a
mean of 2.5 ± 2.3 h; they showed a respiratory rate
decrease from 35 (30, 38) to 27 (25, 35) per min
(p = 0.02) and an inability to increase the PaO2/FiO2
ratio above 180 mmHg. The ICU mortality in the failure
group patients was 50 versus 14% in the NIV success
group (p \ 0.05). It was concluded that a remifentanil-
based sedation strategy is feasible and safe.
Continuous positive airway pressure ventilation with a
helmet was evaluated in infants under 1 year by Milesi
et al. [30]. Twenty-three infants with a median age of 5
(2–8) months were included. Helmet CPAP failed in two
(9%) patients. Stability or improvement occurred in 16
(70%) patients. The pain and discomfort score was stable
or improved in 22 (96%). The authors concluded that the
helmet was a satisfactory interface for CPAP delivery in
young infants in more than two-thirds of the cases.
Weaning
Optimal weaning strategy was assessed by Cabello et al.
[31] in a physiological comparison of three spontaneous
breathing trials (SBTs) in difficult-to-wean patients. The
study aim was to compare cardiovascular and respiratory
responses to different SBTs in difficult-to-wean patients
using T-piece and pressure support ventilation (PSV) with
or without PEEP. Fourteen patients who were monitored
with a Swan–Ganz catheter and had failed a previous
T-piece trial were studied. Three SBTs were performed in
random order in all patients: PSV with PEEP (PSV-
PEEP), PSV without PEEP (PSV-ZEEP), and T-piece.
PSV level was 7 cmH2O, and PEEP was 5 cmH2O. Most
patients succeeded in the PSV-PEEP (11/14) and PSV-
ZEEP (8/14) trials, but all failed the T-piece trial. Patient
effort was significantly higher during T-piece than during
PSV with or without PEEP. Left ventricular heart failure
was observed in 11 of the 14 patients during the T-piece
trial. Pulmonary artery occlusion pressure and respiratory
rate were significantly higher during T-piece than with
PSV-PEEP and tidal volume was significantly lower
during the T-piece trial. The authors’ conclusion was that
in a population of difficult-to-wean patients, PSV and
PSV plus PEEP markedly modified the breathing pattern,
inspiratory muscle effort, and cardiovascular response as
compared with the T-piece. Rapid shallow breathing may
occur at any time during SBTs, questioning the utility of a
single determination of the rapid shallow breathing index
(RSBI). Segal et al. [32] hypothesized that change in
RSBI during SBT may more accurately predict successful
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extubation than RSBI determination at a point in time.
The percent change in RSBI during a 2-h SBT in indi-
vidual subjects was evaluated in a prospective manner.
Seventy-two subjects were extubated. At 24 h, 63/72
remained extubated (Extubation Success), and 9 were re-
intubated (Extubation Failure). Respiratory rate, tidal
volume (VT) and RSBI were measured every 30 min
during the 2-h T-piece SBT. Initial RSBI was similar in
Extubation Success and Extubation Failure groups
(77.0 ± 4.8, 77.0 ± 4.8, p = not significant), and RSBI
tended to remain unchanged or decreased in the Extuba-
tion Success group. However, RSBI tended to increase in
the Extubation Failure group because of either increased
respiratory rate and/or decreased VT (p \ 0.001 for mean
percent change RSBI over time). Only 7/63 subjects of
the Extubation Success group demonstrated increased
RSBI C 20% at any time during the SBT. In contrast, in
the Extubation Failure group, RSBI increased in all subjects
during the SBT, and eight of nine subjects demonstrated an
increase greater than 20%. Thus, with a 2-h SBT the optimal
threshold was a 20% increase (sensitivity = 89%, specific-
ity = 89%). Percent change of RSBI predicted successful
extubation even when initial values were C105. Segal et al.
concluded that the change in RSBI is a marker of dynamic
changes that occur during weaning that may improve the
ability to predict extubation outcome.
The SBT relies on objective criteria assessed by the
clinician. However, little is known regarding the patient’s
subjective perception of autonomous breathing. A pro-
spective observational study in 211 mechanically
ventilated adult patients successfully completing a SBT
analysed this specific subject [33]. Patients were ran-
domly assigned to be interviewed during this trial
regarding their prediction of extubation success. The post-
extubation outcomes were compared in three patient
groups: patients confident (confidents; n = 115) or not
(non-confidents; n = 38) of their extubation success and
patients not subjected to interview (control group;
n = 58). Extubation success was more frequent in conf-
idents than in non-confidents (90 vs. 45%; p \ 0.001/
positive likelihood ratio = 2.00) or in the control group
(90 vs. 78%; p = 0.04). On the contrary, extubation
failure was more common in non-confidents than in
confidents (55 vs. 10%; p \ 0.001/negative likelihood
ratio = 0.19). Logistic regression analysis showed that
extubation success was associated with patient’s predic-
tion [odds ratio (OR) (95% CI) 9.2 (3.74–22.42) for
confidents vs. non-confidents] and with age [0.72
(0.66–0.78) for age 75 vs. 65 and 1.31 (1.28–1.51) for age
55 vs. 65]. It was concluded that at the end of a sustained
SBT, extubation success might be correlated with the
patients’ subjective perception of autonomous breathing.
Sedation during mechanical ventilation is common
clinical practice in the ICU and has important implica-
tions for the duration of mechanical ventilation and
weaning. In June Intensive Care Medicine published a
meta-analysis [34] carried out to assess the effects of
using dexmedetomidine (D) as a sedative and analgesic
agent on length of ICU stay, duration of mechanical
ventilation, risk of bradycardia, and hypotension in criti-
cally ill adult patients. The controls were placebo or an
alternative sedative agent. A total of 2,419 critically ill
patients from 24 trials were subject to meta-analysis. D
was associated with a significant reduction in length of
ICU stay (weighted mean difference -0.48 days, 95% CI
-0.18 to -0.78 days, p = 0.002), but not duration of
mechanical ventilation, when compared with an alterna-
tive sedative agent. There was, however, significant
heterogeneity in these two outcomes between the pooled
studies. D was associated with increased risk of brady-
cardia requiring interventions in studies that used both a
loading dose and maintenance doses greater than 0.7 lg/
kg/h [relative risk (RR) 7.30, 95% CI 1.73–30.81,
p = 0.007]. It was concluded that significant heteroge-
neity existed between the pooled studies, and that the
limited evidence suggested that D might reduce length of
ICU stay in some critically ill patients. However, the risk
of bradycardia was significantly higher when both a
loading dose and high maintenance doses of D were used.
Patients who require mechanical ventilation are at risk
of emotional stress because of total dependence on a
ventilator for breathing and they know that their ability to
breathe depends on assistance from a machine. Because
of the presence of an endotracheal tube, they cannot talk
and it is extremely difficult for most of them to commu-
nicate their needs. The stress may negatively impact
ventilator weaning and survival. Jubran et al. [35] ana-
lysed whether depressive disorders in patients being
weaned from prolonged mechanical ventilation are linked
to weaning failure and decreased survival. A prospective
study of 478 consecutive patients transferred to a long-
term acute care hospital for weaning from prolonged
ventilation was undertaken. A clinical psychologist con-
ducted the interview with patients. Of the 478 patients,
142 had persistent coma or delirium and were unable to
be evaluated for depressive disorders. Of the remaining
336 patients, 142 (42%) were diagnosed with depressive
disorders. In multivariate analysis, co-morbidity score
(OR 1.23, p = 0.007), functional dependence before the
acute illness (OR 1.70, p = 0.03) and history of psychi-
atric disorders (OR 3.04, p = 0.0001) were independent
predictors of depressive disorders. The rate of weaning
failure was higher in patients with depressive disorders
than in those without such disorders (61 vs. 33%, p =
0.0001), as was mortality (24 vs. 10%, p = 0.0008). Ju-
bran et al. concluded that the presence of depressive
disorders was related to factors present before the onset of
the acute respiratory failure and that patients with
depressive disorders were more likely to experience
weaning failure and death.
Weaning from prolonged mechanical ventilation may
be also associated with mental discomfort. The same
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group of authors in another study investigated whether
post-traumatic stress disorder (PTSD) occurs in patients
after weaning from prolonged ventilation and determined
whether a questionnaire administration would identify
patients at risk for developing PTSD [36]. In a prospec-
tive longitudinal study, 72 patients were studied 1 week
after weaning, and 41 patients were studied again
3 months later. An experienced psychologist conducted a
structured clinical interview 3 months after weaning. To
assess for the presence of PTSD-related symptoms, the
post-traumatic stress syndrome (PTSS-10) questionnaire
was administered 1 week after weaning and 3 months
later. PTSD was diagnosed in 12% of patients 3 months
after ventilator weaning. Patients who developed PTSD
were more likely to have a previous history of psychiatric
disorders (p \ 0.02). A PTSS-10 score higher than 20 one
week after weaning reliably identified patients who were
diagnosed with PTSD 3 months later: sensitivity 1.0;
specificity 0.76; area under the receiver-operating char-
acteristic curve (AUC) 0.91. It was concluded that the
development of PTSD was related to the presence of
previous mental difficulties rather than the severity of the
underlying critical illness. A PTSS-10 score higher than
20 one week after weaning identified patients diagnosed
with PTSD 3 months later. This finding suggests that a
simple questionnaire administered before discharge can
identify patients at risk for developing PTSD. This article
has an accompanying editorial comment [37].
Endotracheal intubation and tracheostomy
Endotracheal intubation is one of the most common
procedures performed in the ICU and is associated with
complications. Jaber et al. [38] conducted an investigation
to determine whether the implementation of an intubation
management protocol leads to the reduction of intubation-
related complications in the ICU. To that end, a before–
after study was done in three medical–surgical ICUs in
two university hospitals. All intubations performed during
two consecutive phases (6 months each) were evaluated.
An initial quality control phase was followed by a phase
based on the implementation of an ICU intubation
bundle management protocol. Primary endpoints were
the incidence of life-threatening complications within
60 min after intubation (cardiac arrest, death, cardio-
vascular collapse and hypoxaemia). The intubation
procedure in the intervention (protocol) phase (n = 121)
was associated with significant decreases in both life-
threatening complications (21 vs. 34%, p = 0.03) and
other mild complications (9 vs. 21%, p = 0.01) com-
pared with the control phase (n = 123). No differences
in other outcomes, such as ICU length of stay and
mortality rates, were observed. The authors concluded
that the implementation of an intubation management
protocol can reduce immediate severe life-threatening
complications.
Tadie´ et al. [39] assessed the rate of post-intubation
laryngeal injuries and extubation failure in a prospective
study including 136 patients extubated after more than
24 h of mechanical ventilation. Fibre-optic endoscopic
examination of the larynx was systemically performed
within 6 h after extubation in order to record four types of
laryngeal anomalies: edema, ulceration, granulation and
abnormal vocal cord mobility. Laryngeal injuries occur-
red in 73% of the study population and were associated
with duration of intubation, absence of myorelaxants at
intubation, emergency intubation and height/endotracheal
tube size ratio. Seventeen patients were re-intubated
within 48 h following extubation. Laryngeal examination
of these patients more frequently showed granulation and
abnormal pictures.
Many patients with respiratory failure related to neu-
romuscular disease receive chronic invasive ventilation
through a tracheostomy. Improving quality of life, of
which speech is an important component, is a major goal
in these patients. The effects on breathing and speech of a
low-level (5 cmH2O) PEEP, and of a Passy–Muir
speaking valve (PMV) during assist-control ventilation
was investigated in ten tracheotomized patients [40].
During speech with PEEP, six of the ten patients had no
return of expiratory gas to the expiratory line and,
therefore, had the entire insufflated volume available for
speech, a condition met during PMV use in all patients.
During speech, the respiratory rate increased by at least
3 cycles/min above the backup rate in seven patients with
PEEP and in none of the patients with PMV. It was
concluded that low-level PEEP is as effective as PMV in
ensuring good speech quality.
Lung ultrasound
Lung ultrasound is a promising, noninvasive technique for
lung and pleural pathology assessment in critically ill
patients. Whole lung lavage is used to treat pulmonary
alveolar proteinosis and can be considered as a complex
human model of controlled lung de-aeration and its pro-
gressive resolution with PEEP application and diuretics
administration. Via et al. [41] described ultrasound find-
ings during whole lung lavage with validated semiotics
and assessed their relation to the different states of lung
aeration. During one-lung ventilation and saline flooding,
ultrasound findings shifted from normal/nearly normal
pattern and alveolar-interstitial syndrome to alveolar
consolidation. Saline removal, re-ventilation and negative
water balance were associated with a gradual return to
alveolar-interstitial syndrome, then to a normal/nearly
normal pattern. Arterial oxygenation variations were not
always consistent with lung aeration changes. These
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findings showed that lung ultrasound could reliably
describe the different states of aeration determined by the
whole lung lavage procedure and confirmed ultrasound as
an accurate technique for bedside monitoring of lung
pathology.
Pleural effusions (PE) are frequent in the critically ill
and accurate bedside quantification of the PE volume is
challenging. Reme´rand [42] assessed the accuracy of a
multiplane ultrasound approach to measure PE volume.
The goal was to provide an accurate quantification of
small to large PE and to help in the clinical decision
making for thoracic drainage. The was study performed
on 58 critically ill patients with 102 PEs and the PE was
assessed using bedside lung ultrasound. Thoracic drainage
was performed in 46 patients (59 PEs) and lung computed
tomography (CT) in 24 patients (43 PEs). Ultrasound PE
volume was compared with either the volume of the
drained PE or PE volume assessed on lung CT. Ultra-
sound PE volume was correlated with drained PE volume
(r = 0.84, p \ 0.001) and with CT PE volume (r = 0.90,
p \ 0.001). Mean biases between ultrasound and actual
volumes of PE were -33 ml when compared with
drainage (limits of agreement -292 to ?227 ml) and
-53 ml when compared with CT (limits of agreement
-303 to ?198 ml). It was concluded that the multiplane
approach increases the accuracy of lung ultrasound to
measure the volume of large to small PEs and that
this method can be recommended for the assessment of
these PE.
Paediatrics
Respiratory
Whilst the focus of much research into the mechanisms of
lung injury focus on the adult lung, we are reminded by
both Sapru and Tissieres that lung injury occurs at all ages
[43, 44]. Sapru studied the relationship between increased
plasma and pulmonary oedema fluid levels of plasmino-
gen-activator inhibitor-1 (PAF-1), an anti-fibrinolytic
agent which is activated during inflammation, and out-
come of ALI in children. They demonstrated that as in
adults, higher PAF-1 levels are associated with increased
mortality and fewer ventilator-free days in children with
ALI, suggesting that PAF-1 may serve as a useful bio-
marker of prognosis in children with ALI. Tissieres
studied the effect of prophylactic surfactant on pulmonary
outcomes in a group of very low birthweight infants.
Previously, early lung recruitment (ELR) and high fre-
quency oscillatory ventilation (HFOV) in combination
with prophylactic surfactant were reported to reduce
mortality and improve pulmonary outcomes. In this study,
surfactant was only administered to those babies with
unsatisfactory response to ELR. The rationale behind this
approach is that (1) an easily recruitable lung in the early
stage of RDS may not need exogenous surfactant treat-
ment for sufficient lung opening and (2) gentle ventilation
in an ‘‘open lung’’ may preserve surfactant function by
avoiding a major inflammatory stimulus within the lungs,
as suggested by experimental data. The authors showed
that implementation of an ELR strategy with HFOV and
selective surfactant administration resulted in no dis-
cernable detrimental effect on respiratory outcomes and
mortality in VLBW infants presenting with RDS, raising
the question of whether current practice of universal
surfactant administration should be reconsidered. Ulti-
mately, when considering the management of very severe
respiratory failure in term neonates, ECMO has a well-
established place. The report by Schaible [45] describes
the outcomes of neonatal respiratory ECMO from a large
European centre. Overall survival rates of 67% break
down to 94% in babies with meconium aspiration and
62% in those with congenital diaphragmatic hernia. The
report showed a clear association between early referral
and higher rate of survival (77% survival for babies
referred in the first 24 h of life compared with 54% for
those referred at greater than 24 h of age).
Whilst much research focuses on biochemical and
cellular mechanisms of lung injury and repair, important
studies continue to emphasise to clinicians the importance
of understanding lung physiology and the interactions of
the lung with respiratory support systems. For example,
Tingay et al. [46] described the impact of different
endotracheal suction techniques on regional end-expira-
tory lung volume (EELV) and tidal volume in a
surfactant-deficient piglet model. Closed suction (CS)
methods and the use of smaller suction catheters have
been claimed to result in less loss of recruitment during
tracheal suction in neonates. Tingay compared open
suction (OS) with two closed techniques when using
either 5- or 8-French-gauge suction catheters. Their
results question this, as recovery of lung volume and
ventilation after endotracheal tube (ETT) suction was
rapid and uniform throughout the lung with all suction
techniques. Despite the 10- to 14-fold greater loss of
EELV seen during OS, and CS with an 8-FG catheter
compared with 5-FG CS, the regional EELV and VT 10 s
after suction did not differ. This rapid recovery is con-
sistent with studies comparing global DEELV during and
after suction using open and closed methods and suggests
that carefully conducted open suction remains a safe and
effective option. Carlisle et al. [47] from the same
research group also took a step back to basic physiology
in exploring the influence of gravity on the distribution of
ventilation and perfusion within the neonatal chest.
Whereas it is widely recognised that the diseased adult
lung is particularly prone to ventilation–perfusion mis-
matching, even when ventilation has been optimised,
little is known about lung perfusion and the distribution
of blood volume within the preterm lung. Traditional
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methods of determining lung perfusion, such as radionuclide
scans, are not feasible in the ventilated neonate; however, the
development of electrical impedance tomography (EIT) as a
noninvasive, real-time, radiation-free method of measuring
the relative change in impedances within regions of a cross
section of the thorax facilitates the study of changes in gas,
tissue and blood volumes. Air generates a greater impedance
change than blood, and EIT has been used to measure
regional ventilation in newborn infants with recent techno-
logical advances now enabling isolation of the EIT signal
within the cardiac frequency domain thus allowing deter-
mination of cyclical changes in blood volume. Carlisle et al.
demonstrated elegantly that gravity does indeed influence
ventilation–perfusion relationships in the lungs of preterm
infants, a finding which provides evidence to support clinical
practice and future research including the use of positioning
techniques and ventilatory strategies in the management of
preterm lung disease.
In recent years, continuous positive airway pressure
through nasal cannulae (nCPAP) provided to preterm neo-
nates with respiratory failure has been shown to be effective
in stabilizing proximal airways and surfactant-deficient
alveoli, improving oxygenation, and to reduce the need for
intubation. Infants who fail nCPAP may theoretically benefit
from a noninvasive rescue ventilation. In a laboratory bench
experiment, De Luca et al. [48] described the effect of nasal
cannulae of varying diameter on the delivery of ventilation to
a model lung using a widely used HFO ventilator. The
authors concluded in this preliminary study that nasal prong
diameter and flow are the main determinants of the delivered
tidal volume and total ventilation. A great deal of additional
bench and animal work will be required to further explore
this potential extension to the noninvasive ventilatory
armamentarium.
The outbreak of influenza A (H1N1) in the southern
hemisphere during the summer of 2009 heralded similar
surges of H1N1 infection in the northern winter of
2009–2010. Farias et al. [49] reported on the management
and outcomes of 147 children admitted to paediatric inten-
sive care units (PICUs) in Argentina during that period with
H1N1 infection. Of those children, 94% were invasively
ventilated, with a reported mortality of 39%. Of the children
who died, whilst 59% suffered from a chronic medical
condition, 41% were apparently previously healthy. This
report is consistent with others in showing that the mortality
rate from H1N1 influenza A is higher than that usually
recorded for seasonal influenza A, and brings into focus the
deaths of not only ‘at risk’ children, but those with no pre-
vious health concerns. Immunisation programmes need to
take careful account of such reports.
Sepsis and multiorgan failure
Abdominal compartment syndrome (ACS), defined as a
sustained intra-abdominal pressure (IAP) of greater than
20 mmHg, is of concern because it is associated with
multiorgan system failure and has a high mortality rate.
Patient position and body mass index (BMI) affect intra-
abdominal pressure in adults and Ejike et al. [50] explored
factors influencing IAP in 77 mechanically ventilated
children less than 18 years of age. Paired measurements
of IAP were measured in supine and 30 head-up posi-
tions every 6 h over a 24-h period. Mean IAP was
10.6 ± 4.0 mmHg at 30 head up, and 8.4 ± 4.0 mmHg
in the supine position. No correlation was found between
IAP and BMI or BMI percentiles. The authors concluded
that whilst body position should be taken into account
when interpreting IAP, BMI did not seem to influence
IAP in their population of children and young people.
Peroxisome proliferator-activated receptor-c (PPARc)
is a ligand-binding nuclear receptor whose activation
influences the inflammatory response. The mechanism of
cytokine inhibition in activated monocytes/macrophages
occurs, in part, through repression of several inflamma-
tory response genes, including activator protein-1 and
nuclear factor-jB (NF-jB). The endogenous activator of
PPARc, 15d-PGJ2, exerts beneficial anti-inflammatory
effects, in part, through inhibition of NF-jB activation
and it is known that sepsis-induced reduction in PPARc
expression is reversed by in vivo treatment with PPARc
ligands. In a single-centre, prospective case–control study
in critically ill children with systemic inflammatory
response syndrome, sepsis or septic shock Kaplan et al.
[51] determined that PPARc nuclear protein expression
was decreased but PPARc activity was increased in
peripheral blood monocytes from children with septic
shock compared with controls. In addition, Kaplan
investigated the effects of sepsis on 15d-PGJ2 and the
downstream targets of PPARc activity, high-molecular-
weight adiponectin (HMWA) and resistin [51]. Their
results show that PPARc activity on day 1 was signifi-
cantly higher in patients with higher paediatric risk of
mortality (PRISM) score compared with controls. Patients
with resolved sepsis had increased levels of 15d-PGJ2
compared with patients with systemic inflammatory
response syndrome (SIRS) and septic shock. In summary
these findings suggest that sepsis is associated with
altered PPARc expression and activity in monocytes.
Further studies are needed to understand the mechanisms
underlying changes in PPARc and their downstream tar-
gets in sepsis, as potential biomarkers or to inform
therapeutic strategies. Sarafidis et al. [52] reported on the
use of a potential biomarker, specifically serum soluble
triggering receptor expressed on myeloid cells TREM-1,
in the context of the early diagnosis of late-onset sepsis in
neonates. S-TREM-1 and IL6 were measured when signs
of sepsis were evident. Receiver operating curve (ROC)
analysis for s-TREM-1 (AUC 0.733, p = 0.005) com-
pared favourably with IL-6 (AUC 0.892, p = 0.001) for
identification of infected neonates. There was, however,
no statistically significant difference between the two
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biomarkers, and their deployment when sepsis was
already suspected brings into question the general use-
fulness of the markers, given that clinical suspicion had
already been aroused.
Agbeko et al. [53] sought to determine if common
polymorphisms in the endotoxin recognition complex
influenced the acute phase response as determined by the
development of SIRS and platelet count on admission of
children to critical care in a prospective observational
cohort study. Paediatric intensive care patients (n = 913)
were genotyped for common functional polymorphisms in
the endotoxin recognition complex, including Toll-like
receptor 4 (TLR4). TLR4 variant alleles were found to be
associated with lower platelet counts across a range of
ages and precipitating insults but that they do not influ-
ence the incidence of SIRS. This finding may reflect
redundancy and ‘robustness’ in the pathways leading to
SIRS or the lack of specificity of this endpoint. Platelet
count may vary with TLR4 genotype because it may be
sufficiently sensitive and more linearly related to
inflammation than other markers or, alternatively, there
may be a direct TLR4-mediated platelet effect.
Two papers in the paediatric pages of Intensive Care
Medicine reported new approaches to the characterisation
and management of acute adrenal insufficiency in PICU.
Dupuis et al. [54] reported a study in which serial blood
cortisol and adrenocorticotropic hormone (ACTH) levels
were measured in a series of 28 children with traumatic
brain injury (TBI). Secondary adrenal insufficiency was
defined as cortisol below 200 nmol/l with ACTH below
12 pmol/l. Secondary adrenal insufficiency was detected
in 10 (37%) of children and was associated with a range
of adverse clinical endpoints, raising the important
question of whether cortisol replacement is needed in
such TBI patients. A word of caution on measurement and
interpretation of cortisol levels in critical illness is raised
by Zimmerman [55] who points out that whilst histori-
cally adrenal function has been assessed by measuring
total cortisol (TC) there is an evolving consensus that
because free cortisol (FC) rather than protein-bound
cortisol is responsible for the biochemical actions of this
hormone the FC fraction should be measured as ‘func-
tionally important’. This is of particular relevance in
critical illness as levels of cortisol-binding globulin and
other proteins which bind cortisol such as albumin are
altered. One practical drawback, however, is that the
traditional assay method used to determine plasma-free
cortisol, equilibrium dialysis, required large blood vol-
umes and prolonged fractionation time preceding
analysis. Zimmerman reported a pilot study on the mea-
surement of FC using a chemiluminescence assay,
determining that FC could be measured both accurately
and rapidly (analyser time 38 min) using the new assay
method which requires only 0.4 ml blood. Utilization of
the new method for free FC analysis will require confir-
mation utilizing larger cohorts of both healthy and
critically ill children but suggests that real-time FC
quantification may be available to help guide clinical
decision making regarding cortisol replacement therapy
for children with critical illness.
Views on the usefulness of ECMO in shock are mixed.
It is logical to suppose that in situations where cardiac
dysfunction predominates as is the case in acute fulminant
myocarditis, veno-arterial ECMO can be expected to
support patients effectively. Enterovirus 71 (EV71) is
usually a minor childhood illness, but can occasionally
lead to cardiovascular collapse with acute cardiac
involvement and cardiogenic shock. Jan and colleagues
[56] reported a series of 13 cases of ECMO support in
children with severe EV71 infection of whom 10 were
successfully weaned from ECMO and survived. The
median duration of ECMO support was 93 ± 33 h.
Determining which patients to support with ECMO can be
challenging, but in sepsis, focussing on cases with pre-
dominant cardiac involvement is recommended.
Neurological critical care
Head trauma is an important factor contributing to
childhood morbidity and mortality. Injury is suffered in
two distinct phases. The primary injury occurs at the
moment of impact and results from mechanical forces that
cause direct disruption of the brain parenchyma. The
second phase of injury is a sequelae of events triggered by
the primary injury and includes endogenous factors such
as metabolic, cellular and biochemical derangements and
exogenous factors such as hypoxia and hypotension. Over
the last two decades, several studies have evaluated
vasospasm in adult head trauma patients although the
paediatric literature is extremely sparse. O’Brien [57]
reported the results of a prospective observational study
of 22 children with moderate or severe traumatic brain
injury. Transcranial Doppler ultrasound examinations
were performed to detect and follow vasospasm. Of the
children examined, 45.5% developed vasospasm in the
middle cerebral artery, and 18.2% in the basilar artery
with onset typically on day 2–3. The authors concluded
that vasospasm, however, be an unrecognized phenome-
non contributing to secondary brain injury in paediatric
head trauma patients.
It has long been assumed that age and brain maturity
have important influences on cerebral perfusion pressure
(CPP) and autoregulation. Walter et al. [58] reported an
experimental approach, in which a gradual reduction in
CCP was induced, to estimate the threshold levels of
increased glutamatergic and dopaminergic transmitter
release responsible for excitotoxicity in newborn and
juvenile pigs (i.e. the functional lower limit of cerebral
autoregulation). The resulting effects on CBF and brain
oxidative metabolism were quantified, and striatal
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glutamate and dopamine release were monitored by
microdialysis. The authors showed an age-dependent
threshold difference for significant extracellular glutamate
and dopamine release following a gradual decrease in
CPP. Juvenile pigs showed a marked elevation in the
levels of both transmitters as early as at a moderate
reduction of CPP, whereas this response was not apparent
in newborn piglets which may suggest that the immature
brain is less susceptible to damage through excitotoxic
mechanisms than the more mature brain.
Hypoxia–ischaemia (HI) is a major cause of foetal
brain damage and is effectively untreatable except in a
supportive paradigm. Fathali et al. [59] provided an
intriguing insight into a potential new therapeutic avenue
for such babies in an investigation of the effect of gran-
ulocyte-colony stimulating factor (GCSF) on HI-induced
brain damage in infant rats, following a 2-h period of
carotid ligation accompanied by hypoxia (8% oxygen).
Compared with control animals, GCSF administered daily
for 5 or 10 days following HI appeared to afford long-
term neuroprotection assessed against both morphological
and functional criteria. This interesting finding deserves
further exploration in a clinical setting.
Parents are often frustrated at the inability of clinicians
to accurately predict outcomes in paediatric neurointen-
sive care. Carrai et al. [60] published a review of the
literature on the use of somato-sensory evoked potentials
(SEPs) in comatose children. The authors selected 14
studies covering 732 patients. In individual papers, the
presence of SEP predicted favourable outcomes as shown
by the area under both sROC curves being 0.958. The
same value was shown by SEP absence for predicting
unfavourable outcomes. All covariates showed no sig-
nificant effects on diagnostic accuracy, but only a slight
non-significant trend. For SEP grading, a simple subgroup
analysis showed a high positive predictive value (PPV)
for non-awakening for absence of SEPs (PPV 97.0%) and
a high prognostic power to predict awakening for normal
SEPs (PPV 92.2%). Pathological SEPs did not show
reliable predictivity. In children, the presence of SEPs
showed a high prognostic power similar to that in adults.
The study supports the use of SEPs in the integrated
process of outcome prediction after acute brain injury in
children. Caution is recommended in predicting unfa-
vourable outcomes in patients with an absence of SEPs in
both TBI and hypoxic-ischaemic encephalopathy (HIE)
comas. The authors suggest that future studies are needed
to resolve the issue of the effect of etiology and age on
SEP’s predictive power. This report is, however, an
important snapshot of the current state of knowledge on
the use of SEPs in paediatric coma.
The ‘science’ of improving outcome through better
organisation or delivery of care is having a great impact in
critical care units across the globe. For example the
implementation of well-designed ‘care bundles’ aimed at
for instance reducing nosocomial infection rates have
been shown to be both clinically and economically
effective. Decisions on where care is delivered and how it
is delivered are important but must be informed by good
data describing the population, the intervention or treat-
ment and outcomes. Cogo et al. [61] investigated the
outcomes from the care received by 1,265 Italian children
admitted to adult intensive care units between 2003 and
2007 using data obtained from the ‘Project Margherita’
quality assessment and improvement database comparing
these to a cohort of PICU children from 1994 to 1995.
Using PRISM for risk adjustment, Cogo et al. found that
the standardised mortality ratio was slightly worse for
adult ICU care [1.11 (95% CI 0.91–1.31)] than for PICU
care [1.04 (95% CI 0.88–1.19)]. The most important
message from this paper is not, however, that promul-
gated by the author, i.e. that PICU care is best, but is
rather that to measure performance in a healthcare system,
prospective, relevant data are needed. Just as in clinical
research, when measuring quality, safety, outcomes or
managing cost, data is king.
Straney et al. [62] developed models to determine the
efficiency of PICUs contributing data to the Australian
and New Zealand Paediatric Intensive Care (ANZPIC)
Registry which collects data from all of the nine specialist
PICUs in Australia and New Zealand. Length of stay
(LoS) has been cited widely as a suitable marker for
quantifying resource usage. However, efforts to compare
LoS have been hampered by the difficulty in calibrating to
case mix within centres and other local organisational
factors. A method for quantifying variation of mean risk-
adjusted LoS among PICUs was recently reported by
Rapoport et al. [63]. The Rapoport–Teres graph plots
resource usage against clinical performance. It provides a
simple and intuitive method for comparing efficiency
among units and provides a visual representation of cost-
effectiveness. Using this technique, the authors demon-
strated apparent differences in efficiency among PICUs
which may be important for healthcare providers (PICUs)
or healthcare commissioners to understand.
When assessing outcome for operational or research
reasons, mortality is of only limited use in paediatric
intensive care as the rate of mortality is now low and
therefore use of death as an endpoint necessitates large
sample sizes. The paediatric logistic organ dysfunction
(PELOD) score was therefore developed as an outcome
measure for clinical trials in the paediatric intensive care
unit [64]. In the PELOD score markers of organ dys-
function are graded according to severity of derangement
and assigned a score which is then summed in a com-
posite score. The PELOD score has been validated in
several populations in Europe and Canada, but Garcia
et al. [65] recognised the importance of road-testing the
PELOD score as widely as possible. They determined that
the score performed well in discriminating between good
and bad outcomes in children in their two Brazilian PI-
CUs, although the score was poorly calibrated in their
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population (calibration of the score = accuracy of
observed vs. predicted outcomes). This paper, indepen-
dent of the authors of the score, provides a useful insight
into the undoubted strengths and some potential weak-
nesses of what they nevertheless conclude to be a useful
additional PICU scoring tool.
Peeters et al. [66] prospectively examined the risk-
adjusted mortality of children admitted to a large Dutch
intensive care PICU to determine whether ‘out-of-hours’
admission was associated with poorer outcomes than ‘in-
hours’ admission, given that the senior intensivists were
not resident in the hospital out-of-hours. Of the 3,212
admissions studied, 66% occurred in-hours. No difference
in standardised mortality rate was established between in-
and out-of-hours admissions in this single unit. This
report adds to the literature which remains confusing with
some of the few reports on this topic suggesting that hour
of admission or the immediate presence of the most senior
intensivist makes no difference, whilst others suggest that
senior cover improves outcomes.
A strategy widely promoted over recent years in both
adult and paediatric critical care is the use of ‘alert’ or
‘early-warning’ scores to detect deteriorating patients in
non-ICU areas. Chapman et al. [67] systematically
reviewed studies reporting paediatric alert criteria with
assessment of their validity, reliability, clinical effec-
tiveness and clinical utility. Eleven studies were included
and described ten alert criteria. Only three of the five
studies which published the predictive value of paediatric
alert criteria reported appropriate methodology. Only one
study evaluated reliability and no study addressed the
clinical utility of paediatric alert criteria. The authors
therefore had no difficulty in concluding that the evidence
supporting the use of clinical use of paediatric alert cri-
teria is weak and that prospective development and
evaluation are needed before their widespread adoption
into clinical practice.
Naghib et al. [68] reported the outcomes of children
staying more than 28 days in a Dutch PICU. During the
study period 2,607 patients were admitted on 3,700
occasions for a total of 16,013 admission days. Of this
group 4.4% (116/2,607) of patients were identified as very
long-stay patients, consuming 63% (10,055/16,013) of
PICU admission days. Mortality in this group was 5 times
higher (22%) than that for the whole PICU population
(4.6%). The investigators reported that withdrawal or
limitation of care preceded 70% of deaths. This study
emphasises the large burden that prolonged intensive care
dependency places on the child, their family and the
healthcare system. There is a clear need to adopt strate-
gies which promote rapid recovery and therefore reduce
the need for long-term critical care status, but also a need
to provide realistic options for limitation of critical care if
after careful assessment and discussion children are no
longer benefiting from intensive support.
CPR
The development of the scientific basis of cardiopulmo-
nary resuscitation continues to evolve. Iglesias et al. [69]
conducted a comparison of tidal volumes achieved with
ventilation plus compressions (VC) versus chest com-
pressions alone (CC) in 12 infant piglets after induced
hypoxic cardiac arrest. VC achieved a similar tidal vol-
ume to calculated requirements, whereas tidal volume
with CC was very low. The VC technique achieved a
higher pH and PO2 and a lower PCO2 than CC. The
clinical relevance of these findings to clinical practice
remains to be established, although there is some evi-
dence that in the early stages of CPR effective CC alone
may lead to better perfusion of vital organs.
Adrenaline is the recommended drug for the treatment
of cardiac arrest (CA) both in children and adults based
on its vasoconstrictive and inotropic effects. Vasopressin
and terlipressin, a synthetic vasopressin analogue with a
longer half-life, produce vasoconstriction by the stimu-
lation of V1 receptors. Several studies have shown that
vasopressin increases vital organ blood flow and cerebral
oxygen delivery; in addition, adrenaline plus vasopressin
achieved a higher return of spontaneous circulation
(ROSC) and neurological recovery when compared with
adrenaline alone in adult animals with CA secondary to
ventricular fibrillation (VF). Initial clinical studies with
vasopressin plus adrenaline were not found to improve the
results in adult patients with ventricular fibrillation and
pulseless electrical activity compared with adrenaline
alone, but there was an improvement in the results of
resuscitation in cases of asystole and refractory CA. Lo-
pez-Herce [70] compared terlipressin with adrenaline in
an animal model of paediatric asphyxial cardiac arrest.
They determined only a non-significant trend towards
better outcome when terlipressin was combined with
adrenaline compared with either drug alone. Further
evaluations of the role of vasopressin analogues in pae-
diatric CPR are needed.
Drug treatment
Drug handling is notoriously difficult to predict in the
paediatric critical care environment, as organ function
deteriorates, extracorporeal technologies are deployed or
critical interactions occur between drugs. Wildschut et al.
[71] described a simple study in which a range of com-
mon PICU drugs including sedative, analgesics and
antibiotics were added to a range of recirculating neonatal
and paediatric ECMO circuits. Unsurprisingly, lipophilic
drugs such as fentanyl were most likely to be highly
absorbed by the ECMO circuit components, although
some types of ECMO circuit bind less fentanyl than
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others. Morphine is less lipophilic and may therefore be
the opioid of choice during ECMO. Another issue with
drug delivery was highlighted by Jack et al. [72] who
showed in a an elegant animal study that particulate
contamination of infusion solutions can lead to biolog-
ical derangements. The authors confirmed the existence
of particulate contamination in infusions despite a
stringent infusion regime. In vitro investigation of a
number of inflammatory mediators demonstrated that
particulate contaminants had the effect of suppressing
macrophage and endothelial cytokine secretion. The
importance of reducing particulate contamination to
prevent immune modulation is recommended by the
authors.
Two sedation studies in PICU populations were pub-
lished in Intensive Care Medicine in 2010. Daily
interruption of analgeso-sedatives has been recommended
as a component of optimal care in adult critical care
following the landmark paper from Kress et al. [73].
Wildschut et al. [74] reported on the feasibility of anal-
gesia and sedation interruption in 20 neonates on ECMO.
The prospective study was undertaken in a single PICU.
Midazolam and morphine were discontinued after ECMO
cannulations were completed and only restarted based on
COMFORT-B and visual analogue pain nurse-observed
scores. Time without morphine before restart was 10.25 h
(IQR 5–24.1) and time without midazolam was 16.5 h
(IQR 6.6–29.6). No accidental extubations, decannula-
tions or bleeding occurred in patients undergoing sedation
interruption. This study emphasises the surprisingly slow
metabolism of analgo-sedative drugs in the sick neonate
and should encourage the adoption of endpoint-related
drug administration wherever possible, especially in
critically ill neonates with organ dysfunction of critical
illness potentially compounding organ immaturity.
Chrysostomou et al. [75] reported a prospective obser-
vational study of the use of dexmedetomidine in 51
children in PICU with congenital heart disease (CHD).
Dexmedetomidine is a highly selective alpha 2-agonist
with sedative and analgesic properties that has been
shown to reduce the postoperative requirements of addi-
tional intravenous sedative and analgesic agents.
Dexmedetomidine mediates its effects through a complex
mechanism that involves both presynaptic and postsyn-
aptic receptor activation. Activation of the presynaptic
alpha-2 adrenoreceptors on sympathetic nerves and the
central nervous system induces sympatholysis, which is
responsible for the hypotensive and bradycardic side
effects. Although dexmedetomidine appears to have a
wide safety margin, there have been concerns related to
the development of sudden sinus node pauses, symp-
tomatic bradycardia and its potential to cause atrio-
ventricular nodal block and prolongation of the QTc
interval. This study characterised the electrocardiographic
(ECG) effects of dexmedetomidine in children with CHD
and children undergoing cardiothoracic surgery. The
principle findings of this detailed electrophysiological
study showed that in the dexmedetomidine group, heart
rate (HR) decreased from 140 ± 22 to 115 ± 23. When
compared with the control group, none of the ECG
intervals showed any difference other than a trend
towards lower HR (p = 0.08). The use of dexmedetomi-
dine in patients with CHD was not associated with any
clinically significant ECG abnormalities.
Endocrine and metabolic
Plumpton et al. [76] characterised the thyroid hormone
and cortisol concentrations in a prospective observational
study of 52 infants younger than 3 months of age after
congenital heart surgery. In brief, in this well-presented
and data-rich study, infants with low triiodothyronine
(B3.7 pmol/l) or high cortisol concentration on postop-
erative admission to the PICU were more likely to have a
high inotrope requirement on postoperative day 2
(p = 0.003 and p = 0.0006, respectively) or need
mechanical ventilation for longer than 96 h (p = 0.04
and p = 0.002, respectively). Total cortisol concentration
less than 200 nmol/l was found in 16 (31%) infants. Free
cortisol levels were found to follow total cortisol levels
closely in this study. There was no association between
low cortisol and postoperative complications. The authors
speculate on the relevance of these derangements in
endocrine function and the potential to intervene with
supplements to ‘correct’ the abnormalities [76].
Kyle et al. [77] presented a look-back report of the
association between organ dysfunction and hyper-
glycaemia in 110 critically ill children. Organ
dysfunction (C3 versus \3 organs) was significantly
associated with hyperglycaemia for at least 24 h and
hypoglycaemia. There was a trend towards increased
mortality in the hyperglycaemic group. These findings
are not surprising given the reports from many other
ICU populations of similar associations. Whether a
policy of permissive or tight glycaemic control should
be deployed in the management of critically ill adults is
not yet settled [78], and in the paediatric ICU there is
only one published randomised controlled trial which is
supportive of tight glycaemic control [79]. The results
of the CHiP trial, a multicentre trial of tight glycaemic
control versus ‘usual’ care, will complete recruitment in
late 2011 [80].
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